PLX
Price
$1.00
Change
-$0.01 (-0.99%)
Updated
Oct 10 closing price
26 days until earnings call
RARE
Price
$53.87
Change
+$0.49 (+0.92%)
Updated
Oct 10 closing price
18 days until earnings call
Ad is loading...

PLX vs RARE

Header iconPLX vs RARE Comparison
Open Charts PLX vs RAREBanner chart's image
Protalix BioTherapeutics
Price$1.00
Change-$0.01 (-0.99%)
Volume$129.22K
CapitalizationN/A
Ultragenyx Pharmaceutical
Price$53.87
Change+$0.49 (+0.92%)
Volume$561.8K
CapitalizationN/A
View a ticker or compare two or three
PLX vs RARE Comparison Chart
Loading...
PLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PLX vs. RARE commentary
Oct 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLX is a StrongSell and RARE is a StrongSell.

COMPARISON
Comparison
Oct 11, 2024
Stock price -- (PLX: $1.00 vs. RARE: $53.87)
Brand notoriety: PLX and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLX: 84% vs. RARE: 87%
Market capitalization -- PLX: $75.01M vs. RARE: $5.12B
PLX [@Biotechnology] is valued at $75.01M. RARE’s [@Biotechnology] market capitalization is $5.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLX’s FA Score shows that 0 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • PLX’s FA Score: 0 green, 5 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, RARE is a better buy in the long-term than PLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLX’s TA Score shows that 4 TA indicator(s) are bullish while RARE’s TA Score has 4 bullish TA indicator(s).

  • PLX’s TA Score: 4 bullish, 6 bearish.
  • RARE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RARE is a better buy in the short-term than PLX.

Price Growth

PLX (@Biotechnology) experienced а -0.99% price change this week, while RARE (@Biotechnology) price change was +0.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

PLX is expected to report earnings on Mar 13, 2025.

RARE is expected to report earnings on Feb 13, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($5.12B) has a higher market cap than PLX($75M). RARE YTD gains are higher at: 12.652 vs. PLX (-43.820). PLX has higher annual earnings (EBITDA): -12.12M vs. RARE (-486.94M). RARE has more cash in the bank: 764M vs. PLX (45M). PLX has less debt than RARE: PLX (26.2M) vs RARE (37.5M). RARE has higher revenues than PLX: RARE (481M) vs PLX (38.1M).
PLXRAREPLX / RARE
Capitalization75M5.12B1%
EBITDA-12.12M-486.94M2%
Gain YTD-43.82012.652-346%
P/E Ratio13.00N/A-
Revenue38.1M481M8%
Total Cash45M764M6%
Total Debt26.2M37.5M70%
FUNDAMENTALS RATINGS
PLX vs RARE: Fundamental Ratings
PLX
RARE
OUTLOOK RATING
1..100
7661
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
72
Overvalued
PROFIT vs RISK RATING
1..100
10089
SMR RATING
1..100
9699
PRICE GROWTH RATING
1..100
6345
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PLX's Valuation (56) in the Servicestothe Health Industry industry is in the same range as RARE (72) in the Biotechnology industry. This means that PLX’s stock grew similarly to RARE’s over the last 12 months.

RARE's Profit vs Risk Rating (89) in the Biotechnology industry is in the same range as PLX (100) in the Servicestothe Health Industry industry. This means that RARE’s stock grew similarly to PLX’s over the last 12 months.

PLX's SMR Rating (96) in the Servicestothe Health Industry industry is in the same range as RARE (99) in the Biotechnology industry. This means that PLX’s stock grew similarly to RARE’s over the last 12 months.

RARE's Price Growth Rating (45) in the Biotechnology industry is in the same range as PLX (63) in the Servicestothe Health Industry industry. This means that RARE’s stock grew similarly to PLX’s over the last 12 months.

PLX's P/E Growth Rating (99) in the Servicestothe Health Industry industry is in the same range as RARE (100) in the Biotechnology industry. This means that PLX’s stock grew similarly to RARE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLXRARE
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 1 day ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 24 days ago
84%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
82%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
PLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME20.910.41
+2.00%
GameStop Corp
SPY576.13-1.01
-0.18%
SPDR® S&P 500® ETF Trust
AAPL229.04-0.50
-0.22%
Apple
BTC.X60274.500000-307.601560
-0.51%
Bitcoin cryptocurrency
TSLA238.77-2.28
-0.95%
Tesla

PLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with PCVX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
-0.99%
PCVX - PLX
42%
Loosely correlated
-0.24%
NTLA - PLX
41%
Loosely correlated
+0.79%
RCKT - PLX
41%
Loosely correlated
-0.48%
PRME - PLX
38%
Loosely correlated
+0.56%
BEAM - PLX
38%
Loosely correlated
-1.75%
More